NAD: Anti-Aging Claims ‘Muted A Bit,’ But Vigilance Remains High
This article was originally published in The Rose Sheet
Executive Summary
Anti-aging claims in the cosmetics sector show improved compliance with advertising standards overall, but the National Advertising Division remains on the lookout for potential overstatements, particularly as personal-care companies are less inclined to challenge each other than players in other industries.
You may also be interested in...
FDA Clampdown On Excessive Anti-Aging Claims May Lighten Up In 2017
FDA issued close to 30 warning letters to cosmetics firms in 2016 for unapproved drug claims as part of “a project for reviewing product labels and websites for drug claims related to anti-aging.” That initiative may be winding down, if it hasn’t already, but the agency is playing its cards close to its vest going into the new year.
CRN Support For NAD At 10 Years: 250 Ad Claim Reviews, Better Industry Image
"We hoped that it would have legs and it would last," says CRN President and CEO Steve Mister. "We thought, 'If it makes a difference, if we feel like we actually are doing something of value for the industry, we'll keep it up'."
FTC Brings Dot-Com Disclosure Guide To Social Media, Mobile Era
Revised online advertising disclosure guidelines detail FTC’s expectations for how advertisers should craft disclosures in the world of social media and mobile devices.